122 Grants (Page 5 of 5)
1999
DELAVIRDINE MESYLATE FOR HIV 1+NEWLY ENROLLED PTS ALSO IN M/3331/0021
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0674), 12/01/1998 -- 11/30/1999
 
DELAVIRIDINE MESYLATE TREATMENT IN TRIPLE COMBINATION FOR HIV1 PATIENTS
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0503), 12/01/1998 -- 11/30/1999
 
DELAVIRIDINE MESYLATE TREATMENT IN TRIPLE COMBINATION FOR HIV1 PATIENTS
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0503), 12/01/1998 -- 11/30/1999
 
DISCONTINUING THERAPY IN SUBJECTS W/ DISSEMINATED MAC
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0687), 12/01/1998 -- 11/30/1999
 
DOUBLE BLIND, RANDOMIZED, PHASE III STUDY TO EVALUATE VIRAMUNE
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0549), 12/01/1998 -- 11/30/1999
 
DOUBLE BLIND, RANDOMIZED, PHASE III STUDY TO EVALUATE VIRAMUNE
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0549), 12/01/1998 -- 11/30/1999
 
DOUBLE BLIND, RANDOMIZED, PHASE III STUDY TO EVALUATE VIRAMUNE
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0549), 12/01/1998 -- 11/30/1999
 
INTERLEUKIN 2 BY SUBCUTANEOUS INJECTION COMBINED WITH ANTIRETROVIRAL THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0525), 12/01/1998 -- 11/30/1999
 
INTERLEUKIN 2 BY SUBCUTANEOUS INJECTION COMBINED WITH ANTIRETROVIRAL THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0525), 12/01/1998 -- 11/30/1999
 
PHASE II STUDY OF INTERMITTENT RECOMBINANT HUMAN INTERLEUKIN 2
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0614), 12/01/1998 -- 11/30/1999
 
PHASE IV RANDOMIZED STUDY OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0597), 12/01/1998 -- 11/30/1999
 
PHASE IV RANDOMIZED STUDY OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0597), 12/01/1998 -- 11/30/1999
 
PHASE IV RANDOMIZED STUDY OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0597), 12/01/1998 -- 11/30/1999
1998
DELAVIRIDINE MESYLATE TREATMENT IN TRIPLE COMBINATION FOR HIV1 PATIENTS
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0503), 12/01/1997 -- 11/30/1998
 
DOUBLE BLIND, RANDOMIZED, PHASE III STUDY TO EVALUATE VIRAMUNE
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0549), 12/01/1997 -- 11/30/1998
 
INTERLEUKIN 2 BY SUBCUTANEOUS INJECTION COMBINED WITH ANTIRETROVIRAL THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0525), 12/01/1997 -- 11/30/1998
 
PHASE IV RANDOMIZED STUDY OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0597), 12/01/1997 -- 11/30/1998
1997
DOUBLE BLIND, RANDOMIZED, PHASE III STUDY TO EVALUATE VIRAMUNE
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0549), 03/13/1997 -- 11/30/1997
 
HUMAN MONOCLONAL ANTI CYTOMEGALOVIRUS ANTIBODY IN AIDS PATIENTS WITH CMV
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0526), 03/13/1997 -- 11/30/1997
 
INTERLEUKIN 2 BY SUBCUTANEOUS INJECTION COMBINED WITH ANTIRETROVIRAL THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0525), 03/13/1997 -- 11/30/1997
1996
ITRACONAZOLE FOLLOWED BY ORAL DOSING ONCE OR TWICE DAILY IN HIV
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-24-0513), 1996
 
PHASE II RADOMIZED OPEN LABEL TRIAL OF ATOVAQUONE PLUS PYRIMETHAMINE
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-24-0485), 1996